Keyphrases
Anemia
25%
Chemotherapy
25%
Chemotherapy Regimen
25%
Cisplatin
100%
Clinical Setting
25%
Combination Chemotherapy
25%
Combination Regimen
25%
Complete Response
25%
Doxorubicin
100%
Duration of Response
25%
Fever
25%
Less Toxic
25%
Leukopenia
25%
Median Survival
25%
Metastatic Breast Cancer
100%
Methotrexate
100%
Myelosuppression
25%
Objective Response
25%
Oncology
100%
Phase II Trial
100%
Response Rate
25%
Stomatitis
25%
Survival Duration
25%
Vinblastine
100%
Medicine and Dentistry
Anemia
25%
Bone Marrow Suppression
25%
Chemotherapy
25%
Chemotherapy Regimens
25%
Cisplatin
100%
Combination Chemotherapy
25%
Doxorubicin
100%
Leukopenia
25%
Metastatic Breast Cancer
100%
Methotrexate
100%
Oncology
100%
Phase II Trials
100%
Stomatitis
25%
Vinblastine
100%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
25%
Bone Marrow Suppression
25%
Chemotherapy
25%
Chemotherapy Regimens
25%
Cisplatin
100%
Doxorubicin
100%
Leukopenia
25%
Metastatic Breast Cancer
100%
Methotrexate
100%
Phase II Trials
100%
Stomatitis
25%
Vinblastine
100%